Published November 2017 | Version v1
Journal article

Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas

  • 1. Division of Radiation Oncology, MD Anderson Cancer Center, Houston (United States)
  • 2. Department of Radiation Oncology, Hartford Hospital, Hartford (United States)
  • 3. Department of Therapeutic Radiology, Yale School of Medicine, New Haven (United States)
  • 4. Southeast Radiation Oncology Group, Levine Cancer Institute, Charlotte (United States)
  • 5. Department of Radiation Oncology, University of Michigan, Ann Arbor (United States)
  • 6. Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven (United States)

Description

Background and purpose: The role of concurrent chemoradiotherapy (CRT) for anaplastic gliomas is undefined and patterns of care are under-reported. To address the knowledge gap, we examined use of CRT for grade III gliomas compared to radiotherapy (RT) alone.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2017.09.027

Additional details

Identifiers

DOI
10.1016/j.radonc.2017.09.027;
PII
S0167814017325999;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
125
Journal Issue
2
Journal Page Range
p. 258-265
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50081031
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CENTRAL NERVOUS SYSTEM; COMBINED THERAPY; GLIOMAS; RADIOTHERAPY
Descriptors DEC
DISEASES; MEDICINE; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.